Assaf Harofe Medical Center
Be’er Ya‘aqov, 70300, Israel
NCT Number: NCT01837654
The purpose of this study is to find out whether plantarflexion has an effect on the degree of urinary urgency and on the amplitude of detrusor contraction during filling cystometry in patients with detrusor overactivity (DO).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Be’er Ya‘aqov, 70300, Israel
Patients with urodynamic DO will be included in this study. During urodynamics, the mean peak detrusor pressures of each contraction will be documented and compared. At the beginning of the 2nd or 3rd wave, patients will be asked to perform continuous plantar-flexion by pushing their tiptoes against the floor. Following each wave, patients will be asked to grade the severity of the urgency by a visual analogue scale
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All patients with urodynamic detrusor overactivity
Exclusion criteria
Inability to perform plantarflexion due to mental or physical disability
At the beginning of the 2nd wave, patients will be asked to perform continuous plantar-flexion by pushing their tiptoes against the floor.
At the beginning of the 3rd wave, patients will be asked to perform continuous plantar-flexion by pushing their tiptoes against the floor.
Time frame: through test completion, an average of 10 minutes
Mean peak detrusor pressures of each contraction
Time frame: through test completion, an average of 10 minutes
Following each wave, patients will be asked to grade the severity of the urgency by a 0 (minimum) to 10 (maximum) visual analogue scale (VAS).
Assaf-Harofeh Medical Center
Other Gov
Acronym: DO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04270526
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Cambridge, Massachusetts, United States
View Trial DetailsNCT01192568
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Loma Linda, California, United States
View Trial DetailsNCT04197466
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Ankara, Turkey (Türkiye)
View Trial DetailsNCT01781117
Benign Prostatic Hypertrophy With Outflow Obstruction, Female Urogenital Diseases
Seoul, South Korea
View Trial Details